Sharescart Research Club logo

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹555 Cr.
Stock P/E
45.9
P/B
12.3
Current Price
₹261
Book Value
₹ 21.2
Face Value
10
52W High
₹271
52W Low
₹ 156.2
Dividend Yield

KRM Ayurveda Overview

Business

KRM Ayurveda Ltd. operates in the Ayurvedic healthcare segment within India. Its core business likely revolves around providing traditional Ayurvedic medical services and potentially related products. This could include patient consultations, therapeutic treatments, wellness programs, and the sale of Ayurvedic medicines, supplements, or personal care products. The company primarily generates revenue through fees for its services (consultations, treatments) and the sales of its Ayurvedic product range.

Revenue Mix

Specific revenue mix is not available. However, potential key segments would include:

Healthcare Services: Consultations, diagnostic services (if applicable), inpatient and outpatient treatments (e.g., Panchakarma therapies, specialized treatments).

Product Sales: Manufacturing and sale of proprietary Ayurvedic medicines, classical formulations, dietary supplements, and potentially personal care or wellness products.

Wellness & Education: Offering wellness programs, retreats, and educational courses related to Ayurveda.

The relative contribution of these segments would depend on the company's operational focus (e.g., primarily clinics, a hospital, or product manufacturing).

Industry

KRM Ayurveda Ltd. operates within the Hospital & Healthcare Services sector, specifically targeting the Ayurvedic healthcare industry in India. This industry is highly fragmented, comprising numerous small clinics, individual practitioners, and a growing number of organized players, including large pharmaceutical companies and consumer goods giants with Ayurvedic product lines (e.g., Dabur, Himalaya, Patanjali, Baidyanath). The market is characterized by increasing consumer interest in natural and holistic wellness solutions. KRM Ayurveda likely positions itself as a provider of authentic Ayurvedic treatments and quality products, potentially carving out a niche based on specialization, regional presence, or specific product offerings.

MOAT

For an Ayurvedic company, potential competitive advantages (moats) often stem from:

Brand Reputation & Trust: A strong brand built on the efficacy and authenticity of treatments and products, fostering patient loyalty. This is crucial in traditional medicine.

Clinical Expertise: A team of highly qualified and experienced Ayurvedic practitioners who can deliver superior outcomes.

Proprietary Formulations/Treatments: Unique or highly effective Ayurvedic formulations or treatment protocols developed through R&D or extensive clinical practice.

Quality Control: Rigorous standards in sourcing raw materials and manufacturing processes for products.

Network Effect: If it establishes a wide chain of clinics/hospitals, though this is less common for specialized Ayurvedic players initially.

Without further information, it is difficult to ascertain the strength of KRM Ayurveda's moat, but its success will largely depend on building and maintaining a strong reputation for efficacy and trust.

Growth Drivers

Increasing Demand for Traditional Medicine: Growing global and domestic preference for natural, holistic, and preventive healthcare, especially post-pandemic.

Wellness Tourism: India's rising prominence as a destination for Ayurvedic treatments and wellness retreats.

Government Support: Initiatives by the Indian government to promote AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homoeopathy) systems.

Lifestyle Diseases: Ayurveda's potential role in managing chronic lifestyle-related diseases is drawing more attention.

Market Expansion: Opening new clinics, hospitals, or expanding product distribution channels across India or internationally.

Product Innovation: Introducing new or improved Ayurvedic products based on research and consumer needs.

Risks

Intense Competition: Significant competition from both organized (large FMCG/pharma players) and unorganized players in the Ayurvedic market.

Regulatory Changes: Potential changes in AYUSH regulations, quality control standards, or labeling requirements that could impact operations or product formulations.

Reputation Risk: Any negative perception regarding the efficacy or safety of Ayurvedic treatments or products could severely impact public trust and demand.

Talent Scarcity: Challenges in attracting and retaining highly skilled and experienced Ayurvedic practitioners.

Raw Material Sourcing: Dependency on specific herbs and natural ingredients, making it susceptible to supply chain disruptions, price volatility, and quality control issues.

Standardization Challenges: Difficulty in standardizing Ayurvedic treatments and product efficacy, which can affect wider acceptance and scientific validation.

Management & Ownership

Specific details regarding promoters, management quality, and ownership structure are not available. In many Indian companies, particularly in traditional sectors, the business is often promoter-led, with the vision and operational expertise of the founding family or individuals playing a crucial role. The success of KRM Ayurveda would largely depend on the management's ability to navigate a competitive and evolving market, maintain the authenticity and quality of its offerings, and execute growth strategies effectively.

Outlook

KRM Ayurveda Ltd. operates in a promising segment of the Indian healthcare market, driven by increasing consumer preference for traditional and holistic wellness solutions. The overall demand for Ayurvedic services and products is on an upward trajectory, supported by growing health consciousness and government initiatives. However, the company faces significant challenges, primarily from intense competition (including well-capitalized established brands), the need to consistently maintain high standards of quality and authenticity, and navigating evolving regulatory landscapes. Its success will hinge on its ability to build a strong, trusted brand, differentiate its offerings, ensure consistent efficacy of its treatments and products, and effectively scale its operations while retaining its core values.

KRM Ayurveda Share Price

Live · NSE · Inception: 2019
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

KRM Ayurveda Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

KRM Ayurveda Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 89 67 77
Other Income 0 0 0
Total Income 89 68 77
Total Expenditure 78 60 57
Operating Profit 11 8 20
Interest 1 2 2
Depreciation 1 1 1
Exceptional Income / Expenses 0 0 0
Profit Before Tax 10 5 16
Provision for Tax 2 1 4
Profit After Tax 8 3 12
Adjustments 0 0 0
Profit After Adjustments 8 3 12
Adjusted Earnings Per Share 5.1 2.3 8.1

KRM Ayurveda Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 8 12 24
Minority's Interest 0 0 0
Borrowings 18 21 19
Other Non-Current Liabilities 0 0 1
Total Current Liabilities 13 11 24
Total Liabilities 39 44 67
Fixed Assets 23 23 27
Other Non-Current Assets 0 0 1
Total Current Assets 16 21 39
Total Assets 39 44 67

KRM Ayurveda Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 0 1
Cash Flow from Operating Activities 4 -1 -0
Cash Flow from Investing Activities -23 -0 -4
Cash Flow from Financing Activities 19 1 6
Net Cash Inflow / Outflow 0 0 2
Closing Cash & Cash Equivalent 1 1 2

KRM Ayurveda Ratios

# Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 5.07 2.27 8.06
CEPS(Rs) 5.49 2.95 8.76
DPS(Rs) 0 0 0
Book NAV/Share(Rs) 5.58 7.85 15.92
Core EBITDA Margin(%) 12.53 11.33 25.44
EBIT Margin(%) 11.91 10.43 24.6
Pre Tax Margin(%) 11.3 7.04 21.34
PAT Margin (%) 8.51 5.08 15.8
Cash Profit Margin (%) 9.23 6.6 17.17
ROA(%) 19.26 8.19 21.86
ROE(%) 90.82 33.88 67.86
ROCE(%) 37.67 22.17 41.83
Receivable days 31.72 36.13 42.11
Inventory Days 2.76 5.77 21.8
Payable days 100.32 163.45 176.74
PER(x) 0 0 0
Price/Book(x) 0 0 0
Dividend Yield(%) 0 0 0
EV/Net Sales(x) 0.22 0.34 0.38
EV/Core EBITDA(x) 1.75 2.84 1.47
Net Sales Growth(%) 0 -24.79 13.99
EBIT Growth(%) 0 -34.15 168.79
PAT Growth(%) 0 -55.09 254.53
EPS Growth(%) 0 -55.09 254.53
Debt/Equity(x) 2.38 1.97 1.31
Current Ratio(x) 1.18 1.84 1.66
Quick Ratio(x) 1.13 1.71 1.33
Interest Cover(x) 19.26 3.07 7.56
Total Debt/Mcap(x) 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +15%
Operating Profit CAGR +150%
PAT CAGR +300%
Share Price CAGR
ROE Average +68% +64% +64% +64%
ROCE Average +42% +34% +34% +34%

KRM Ayurveda Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 69.15 %
FII 3.86 %
DII (MF + Insurance) 3.16 %
Public (retail) 30.85 %
# Mar 2026
Promoter 69.15
FII 3.86
DII 3.16
Public 30.85
Others 0
Total 100

KRM Ayurveda Peer Comparison

Hospital & Healthcare Services Edit Columns

KRM Ayurveda Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

KRM Ayurveda Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 64%
  • Company has reduced debt.

Cons

  • Debtor days have increased from 163.45 to 176.74days.
  • Stock is trading at 12.3 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp